Penserra Capital Management LLC Uro Gen Pharma Ltd. Transaction History

Penserra Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$9.03 - $19.13 $4,605 - $9,756	-510 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$15.2 - $20.94 $228 - $314	15 Added 3.03%	510 $7,000
Q1 2021 May 13, 2021	SELL	$17.99 - $26.96 $179 - $269	-10 Reduced 1.98%	495 $9,000
Q4 2020 Feb 12, 2021	BUY	$17.54 - $25.43 $5,525 - $8,010	315 Added 165.79%	505 $9,000
Q3 2020 Nov 13, 2020	BUY	$18.81 - $26.42 $3,573 - $5,019	190 New	190 $3,000

113

24M

46.9K

44.3K

Ticker URGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 22,740,500
Market Cap $373M
Description
UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.